Senores Pharmaceuticals Limited has informed the Exchange about the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2025
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has submitted a certificate to the stock exchange under Regulation 74(5) of SEBI's Depositories and Participants Regulations, 2018 for the quarter ended September 30, 2025. This certificate is issued by the company's Registrar and Transfer Agent (RTA) and confirms that the company's share registers are being properly maintained, with no mismatch between physical and dematerialized holdings. The filing covers Q2 FY26 and is part of standard quarterly compliance duties. It is a routine procedural submission required of all listed companies and does not relate to any business, financial, or operational event. Investors should view this as housekeeping rather than news.
No material impact on shareholders or stock price. This is a routine regulatory compliance filing with no bearing on company fundamentals or business activity.